feed,title,long_url,short_url
Benzinga,Dassault Clocks 11% Revenue Growth In Q2,https://benzinga.com/news/earnings/22/07/28204003/dassault-clocks-11-revenue-growth-in-q2,https://bit.ly/3viX4nD
Benzinga,Reneo Pharmaceuticals Says Metabolic Disorder Program To Enter Next Stage Of Development,https://benzinga.com/general/biotech/22/07/28205319/reneo-pharmaceuticals-says-metabolic-disorder-program-to-enter-next-stage-of-development,https://bit.ly/3J7Et3N
